Chlorotrianisene
| | |
| Chlorotrianisene
| |
| Systematic (IUPAC) name | |
| 1-[2-chloro-1,2-bis (4-methoxyphenyl)- ethenyl]- 4-methoxy-benzene | |
| Identifiers | |
| CAS number | |
| ATC code | G03 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C23H21ClO3 |
| Mol. mass | 380.864 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 50 to 80% |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
|
WikiDoc Resources for Chlorotrianisene | |
|
Articles | |
|---|---|
|
Most recent articles on Chlorotrianisene Most cited articles on Chlorotrianisene | |
|
Media | |
|
Powerpoint slides on Chlorotrianisene | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Chlorotrianisene at Clinical Trials.gov Trial results on Chlorotrianisene Clinical Trials on Chlorotrianisene at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Chlorotrianisene NICE Guidance on Chlorotrianisene
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Chlorotrianisene Discussion groups on Chlorotrianisene Patient Handouts on Chlorotrianisene Directions to Hospitals Treating Chlorotrianisene Risk calculators and risk factors for Chlorotrianisene
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Chlorotrianisene | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Business | |
|
Experimental / Informatics | |
Chlorotrianisene is a synthetic estrogen.
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies